Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | LPL | P06858 | 2/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20224581 | 1.00 | PGR (0.35) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL16250086 | 0.99 | PGR (0.35) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL16855491 | 0.99 | PGR (0.35) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL18732173 | 0.98 | PGR (0.35) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL20224572 | 0.95 | PGR (0.35) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL16491819 | 0.94 | PGR (0.36) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL18731709 | 0.92 | PGR (0.38) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL16491829 | 0.89 | CSF1R (0.37) | PGRCSF1RPRMT5WDR77LPL | |
| SCHEMBL16745234 | 0.89 | LPL (0.36) | PGRCSF1RALOX5PRMT5WDR77 | |
| SCHEMBL19862386 | 0.88 | PRMT5 (0.33) | PGRCSF1RPRMT5WDR77LPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2021-11-23 | — | — | US | disclosed |
| US-20180159044-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
| US-20180159044-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | ORC3, ZYX, ESR1 | PGR 2084/4885CSF1R 3662/4885ALOX5 2066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.